DEF: CaliberCos Seeks Shareholder OK for Stock, Equity Plan Boost
Proxy Statement
CaliberCos Inc. will hold a Special Meeting on January 30, 2026, to vote on increasing authorized Class A common stock, amending written consent rules, and expanding its equity incentive plan.
Summary
- A Special Meeting of Stockholders is scheduled for January 30, 2026, to consider and act upon four key proposals.
- Proposal 1 seeks to increase the number of authorized Class A common stock shares from 100,000,000 to 500,000,000.
- Proposal 2 aims to amend the Certificate of Incorporation to permit stockholders to take action by less than unanimous written consent.
- Proposal 3 proposes to amend the 2024 Equity Incentive Plan by increasing shares available for awards by 1,000,000 and incorporating annual increases equal to 15% of outstanding Class A common stock from January 1, 2027, to January 1, 2034.
- Proposal 4 is for the adjournment of the Special Meeting, if necessary, to establish a quorum or solicit additional proxies.
- As of the record date, December 31, 2025, there were 6,534,319 shares of Class A Common Stock and 370,822 shares of Class B Common Stock outstanding.
- The Board of Directors unanimously recommends a vote FOR all four proposals.
- John C. Loeffler, II (Chairman and CEO) and Jennifer Schrader (President) jointly control 54.3% of the total voting power through their ownership of Class B Common Stock.
Sentiment
Score: 5
Explanation: While the proposals aim to provide corporate flexibility and incentivize personnel, the significant potential for shareholder dilution from the massive increase in authorized shares and the expanded equity plan, coupled with the concentration of voting power in management, presents notable concerns for existing shareholders. The benefits are long-term strategic flexibility, but the immediate impact is potential dilution and increased management control.
Positives
- The significant increase in authorized Class A common stock provides the company with necessary flexibility for future capital raising, potential strategic transactions (including mergers and acquisitions), stock splits, and general corporate working capital needs.
- The expansion of the 2024 Equity Incentive Plan is intended to enhance the company's ability to attract, retain, and motivate highly-qualified employees and non-employee directors by offering them proprietary interest in the company.
- Permitting stockholder action by less than unanimous written consent could enable the company to take prompt action on corporate opportunities without the delay and expense of convening a physical stockholder meeting.
Negatives
- The proposed increase in authorized Class A common stock from 100,000,000 to 500,000,000 shares introduces a substantial potential for dilution of current stockholders' voting rights and ownership percentage if new shares are issued.
- The expansion of the 2024 Equity Incentive Plan, including an immediate 1,000,000 share increase and annual 15% increases, will lead to further dilution for existing shareholders through equity awards.
- The ability for stockholders to act by less than unanimous written consent, combined with the CEO and President's majority voting control (54.3%), could allow them to pass significant actions without broader stockholder consensus, potentially overriding minority shareholder interests.
Risks
- **Dilution Risk:** Future issuance of the additional 400,000,000 authorized Class A common shares could significantly dilute the voting rights and ownership percentage of current stockholders.
- **Anti-Takeover Effect:** The increased authorized shares could be issued to dilute the stock ownership or voting rights of persons seeking to obtain control of the company, potentially making hostile takeovers or changes in management more difficult.
- **Equity Compensation Dilution:** The expanded 2024 Equity Incentive Plan, with an additional 1,000,000 shares and annual 15% increases, will lead to ongoing dilution from equity awards, impacting per-share value.
- **Concentrated Control:** The CEO and President, holding 54.3% of the total voting power, can significantly influence or control the outcome of proposals, potentially overriding the interests of other shareholders, especially with the proposed less than unanimous written consent amendment.
Future Outlook
The company aims to enhance its ability to attract, retain, and motivate highly-qualified employees and non-employee directors through an expanded equity incentive plan. The increase in authorized shares is intended to provide necessary flexibility for future capital raising, strategic transactions, and general corporate working capital needs, allowing the company to take timely advantage of market conditions and opportunities.
Management Comments
- The Board of Directors believes that it is in the best interests of the Company and our stockholders to amend the Certificate of Incorporation to increase the number of authorized shares of Class A Common Stock.
- The Board of Directors believes that additional authorized shares of Class A Common Stock would give the Company the necessary flexibility to issue shares for various corporate purposes, including, in particular, raising capital, and enable the Company to take timely advantage of market conditions and opportunities.
- The Board of Directors believes that the proposed Written Consent Amendment would be in the best interests of the Company and our stockholders because it will allow us, in situations where we can obtain the requisite consent in writing, to take prompt action with respect to corporate opportunities that develop, without the delay and expense of convening a stockholder meeting for the purpose of approving the action.
- The Board of Directors believes that the success of the Company is largely dependent on its ability to attract, retain and motivate highly-qualified employees and non-employee directors, and that by continuing to offer them the opportunity to acquire or increase their proprietary interest in the Company, the Company will enhance its ability to attract, retain and motivate such persons.
Industry Context
N/A
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Increase the number of shares of Class A common stock authorized for issuance from 100,000,000 to 500,000,000. | Upon filing of Certificate of Amendment in 2026 (if approved) | Provides significant flexibility for capital raising and strategic transactions, but introduces substantial potential for shareholder dilution and could have anti-takeover effects. |
| Amendment to Certificate of Incorporation | Permit stockholders to take action by less than unanimous written consent. | Upon filing of Certificate of Amendment in 2026 (if approved) | Allows for more efficient corporate action without convening a meeting, but concentrates power with majority shareholders (CEO and President) who can act without full consensus. |
| Amendment to Equity Incentive Plan | Increase shares available for grant by 1,000,000 and incorporate annual increases of 15% of outstanding Class A common stock from January 1, 2027, to January 1, 2034. | Upon stockholder approval (Board approved Dec 9, 2025) | Aims to attract and retain talent through equity compensation, but will lead to ongoing dilution for existing shareholders. |
Stakeholder Impact
- **Shareholders:** Potential for significant dilution of voting power and ownership percentage due to increased authorized shares and expanded equity plan. The ability for less than unanimous written consent could reduce minority shareholder influence.
- **Employees/Non-employee Directors:** Benefit from increased opportunities for equity compensation through the expanded 2024 Equity Incentive Plan, enhancing retention and motivation.
- **Management:** Gains increased flexibility for corporate financing and strategic maneuvers through additional authorized shares. The less than unanimous written consent proposal, combined with their majority voting power, strengthens their ability to enact corporate actions.
Next Steps
- Hold a Special Meeting of Stockholders on January 30, 2026, to vote on the proposals.
- If approved, file a Certificate of Amendment with the Delaware Secretary of State to implement the increase in authorized Class A common stock.
- If approved, file a Certificate of Amendment with the Delaware Secretary of State to permit stockholder action by less than unanimous written consent.
- If approved, the 2024 Equity Incentive Plan will be amended to increase shares and incorporate annual increases.
- Announce preliminary voting results at the Special Meeting and publish final results in a Current Report on Form 8-K within four business days.
- Stockholders wishing to include proposals for the 2026 Annual Meeting must submit them by February 17, 2026.
- Stockholder proposals or director nominations for the 2026 Annual Meeting must be received between April 3, 2026, and May 3, 2026.
Key Dates
| Date | Description |
|---|---|
| 2018-06-07 | Date of initial Certificate of Incorporation filing with Delaware Secretary of State. |
| 2023-05-15 | Donnie R. Schrader's Form 3 filed. |
| 2023-05-16 | Third Amended and Restated Certificate of Incorporation filed. |
| 2024-11-26 | Certificate of Designation filed, amending Certificate of Incorporation. |
| 2025-01-20 | Deadline for beneficial owners to obtain a legal proxy to vote at the Special Meeting. |
| 2025-03-05 | Certificate of Designation filed, amending Certificate of Incorporation. |
| 2025-04-21 | Certificate of Amendment filed, amending Certificate of Incorporation. |
| 2025-06-02 | Deadline for stockholders to provide notice for director nominees under universal proxy rules for the 2026 Annual Meeting. |
| 2025-09-11 | Certificate of Designation filed, amending Certificate of Incorporation. |
| 2025-12-09 | Board of Directors approved the Plan Amendment, subject to stockholder approval. |
| 2025-12-31 | Record date for determining stockholders entitled to notice of and to vote at the Special Meeting. |
| 2026-01-06 | Closing sale price of common stock on The Nasdaq Capital Market was $1.52 per share. |
| 2026-01-07 | Date of the Proxy Statement. |
| 2026-01-09 | Anticipated mailing date of Proxy Statement, Notice of Meeting, and Proxy Card. |
| 2026-01-29 | Internet voting facilities for stockholders of record available until 11:59 p.m., Eastern Time. |
| 2026-01-30 | Date of the Special Meeting of Stockholders at 9:00 a.m. Pacific Standard Time. |
| 2026-02-17 | Deadline for stockholders to submit proposals for inclusion in proxy materials for the 2026 Annual Meeting. |
| 2026-04-03 | Earliest date for stockholder proposals or director nominations for the 2026 Annual Meeting to be received by Corporate Secretary. |
| 2026-05-03 | Latest date for stockholder proposals or director nominations for the 2026 Annual Meeting to be received by Corporate Secretary. |
| 2027-01-01 | Beginning date for annual increases under the 2024 Equity Incentive Plan. |
| 2034-01-01 | Ending date for annual increases under the 2024 Equity Incentive Plan and termination date of the 2024 Plan. |
Recommendation
holdThe filing outlines proposals that, if approved, would grant CaliberCos Inc. substantial flexibility for future capital raises and strategic initiatives, and enhance its ability to attract and retain talent through an expanded equity incentive plan. These are generally positive for long-term growth potential. However, the proposed 400% increase in authorized Class A common stock and the significant expansion of the equity incentive plan introduce a high potential for shareholder dilution. Furthermore, the amendment allowing action by less than unanimous written consent, coupled with the CEO and President's majority voting control, could concentrate decision-making power and potentially override minority shareholder interests. Given the balance between strategic flexibility and the considerable dilution risk, a 'hold' recommendation is appropriate for existing investors to monitor how these new authorizations are utilized and their impact on per-share value, while new investors should approach with caution due to the inherent dilution potential.
Keywords
CaliberCos, SEC Filing, Proxy Statement, Stockholder Meeting, Class A Common Stock, Authorized Shares, Equity Incentive Plan, Stock Dilution, Corporate Governance, Written Consent, Executive Compensation, Capital Raise, Mergers Acquisitions, NASDAQ
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.